The interaction between lymphocyte expressed programmed cell death receptor (PD-1) and its ligand (PD-L1), expressed in malignant cells, induces the inhibition of T-cells during long-term antigen exposure, thus preventing efficient T-cell mediated anti-tumor responses [4]. The gene discussed is CD274; the disease is neoplasm.